| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Genetic | 41 | 2019 | 3431 | 2.220 |
Why?
|
| Genetic Linkage | 21 | 2019 | 2340 | 1.900 |
Why?
|
| Nuclear Family | 15 | 2017 | 311 | 1.820 |
Why?
|
| Family | 30 | 2019 | 3193 | 1.310 |
Why?
|
| Models, Statistical | 36 | 2012 | 5073 | 1.210 |
Why?
|
| Likelihood Functions | 19 | 2012 | 991 | 1.120 |
Why?
|
| Genetic Predisposition to Disease | 50 | 2023 | 17878 | 1.050 |
Why?
|
| Genetic Markers | 24 | 2012 | 2601 | 1.020 |
Why?
|
| Linkage Disequilibrium | 23 | 2019 | 1994 | 0.790 |
Why?
|
| Biometry | 12 | 2009 | 561 | 0.730 |
Why?
|
| Chromosome Mapping | 13 | 2010 | 4611 | 0.720 |
Why?
|
| Longitudinal Studies | 36 | 2015 | 14591 | 0.620 |
Why?
|
| Genetics, Population | 6 | 2013 | 935 | 0.620 |
Why?
|
| Polymorphism, Single Nucleotide | 45 | 2017 | 15908 | 0.610 |
Why?
|
| Statistics as Topic | 7 | 2017 | 2358 | 0.600 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 12 | 2023 | 3204 | 0.590 |
Why?
|
| Data Interpretation, Statistical | 23 | 2011 | 2689 | 0.580 |
Why?
|
| Quantitative Trait Loci | 8 | 2008 | 2112 | 0.570 |
Why?
|
| Genome-Wide Association Study | 23 | 2023 | 12661 | 0.560 |
Why?
|
| Haplotypes | 18 | 2017 | 2713 | 0.550 |
Why?
|
| Phenotype | 33 | 2023 | 16571 | 0.550 |
Why?
|
| Genetic Variation | 12 | 2017 | 6561 | 0.520 |
Why?
|
| Computer Simulation | 25 | 2019 | 6233 | 0.450 |
Why?
|
| Asthma | 18 | 2013 | 6233 | 0.450 |
Why?
|
| Bibliometrics | 1 | 2017 | 352 | 0.430 |
Why?
|
| Pedigree | 11 | 2019 | 4539 | 0.410 |
Why?
|
| Body Mass Index | 14 | 2011 | 12943 | 0.390 |
Why?
|
| Quantitative Trait, Heritable | 7 | 2007 | 540 | 0.380 |
Why?
|
| Serpin E2 | 1 | 2011 | 48 | 0.370 |
Why?
|
| Genetic Testing | 11 | 2011 | 3533 | 0.360 |
Why?
|
| Genetic Techniques | 3 | 2011 | 428 | 0.360 |
Why?
|
| Smoking | 11 | 2017 | 9050 | 0.350 |
Why?
|
| Linear Models | 16 | 2013 | 5866 | 0.350 |
Why?
|
| Meta-Analysis as Topic | 6 | 2015 | 1380 | 0.350 |
Why?
|
| Gene Frequency | 20 | 2019 | 3601 | 0.330 |
Why?
|
| Bipolar Disorder | 9 | 2011 | 5091 | 0.320 |
Why?
|
| Pulmonary Emphysema | 3 | 2023 | 684 | 0.320 |
Why?
|
| Genome, Human | 15 | 2017 | 4421 | 0.320 |
Why?
|
| Environment | 4 | 2010 | 1123 | 0.320 |
Why?
|
| Clinical Trials as Topic | 24 | 2011 | 7995 | 0.310 |
Why?
|
| Genotype | 29 | 2010 | 12978 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2010 | 367 | 0.310 |
Why?
|
| Regression Analysis | 13 | 2007 | 6338 | 0.310 |
Why?
|
| Epistasis, Genetic | 1 | 2010 | 350 | 0.300 |
Why?
|
| Software | 9 | 2019 | 4431 | 0.290 |
Why?
|
| Genes, X-Linked | 1 | 2007 | 128 | 0.280 |
Why?
|
| Algorithms | 25 | 2017 | 14018 | 0.280 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2010 | 604 | 0.280 |
Why?
|
| Genetic Association Studies | 3 | 2019 | 2734 | 0.270 |
Why?
|
| Survival Analysis | 7 | 2004 | 10073 | 0.270 |
Why?
|
| Obesity | 16 | 2012 | 12933 | 0.270 |
Why?
|
| Humans | 205 | 2023 | 760617 | 0.270 |
Why?
|
| Genes | 1 | 2010 | 1823 | 0.270 |
Why?
|
| Family Relations | 1 | 2008 | 315 | 0.260 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 1463 | 0.260 |
Why?
|
| Chromosomes, Human, X | 1 | 2007 | 321 | 0.260 |
Why?
|
| Mass Media | 1 | 2008 | 302 | 0.250 |
Why?
|
| Case-Control Studies | 26 | 2014 | 22148 | 0.250 |
Why?
|
| Body Weight | 11 | 2012 | 4614 | 0.250 |
Why?
|
| Emphysema | 2 | 2023 | 238 | 0.250 |
Why?
|
| Genetic Loci | 4 | 2017 | 2624 | 0.250 |
Why?
|
| Inheritance Patterns | 1 | 2007 | 341 | 0.240 |
Why?
|
| Biostatistics | 3 | 2011 | 163 | 0.230 |
Why?
|
| Alleles | 16 | 2017 | 6861 | 0.230 |
Why?
|
| Epidemiologic Methods | 4 | 2009 | 1335 | 0.230 |
Why?
|
| Logistic Models | 15 | 2004 | 13245 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2005 | 453 | 0.220 |
Why?
|
| Research Design | 15 | 2017 | 6174 | 0.210 |
Why?
|
| Disease | 1 | 2008 | 670 | 0.210 |
Why?
|
| Peer Group | 1 | 2008 | 692 | 0.210 |
Why?
|
| Pharmacogenetics | 3 | 2011 | 675 | 0.190 |
Why?
|
| Multivariate Analysis | 11 | 2011 | 12043 | 0.190 |
Why?
|
| Bulimia | 4 | 2008 | 400 | 0.180 |
Why?
|
| Motor Activity | 1 | 2011 | 2714 | 0.180 |
Why?
|
| Physical Examination | 1 | 2007 | 1254 | 0.180 |
Why?
|
| Sample Size | 4 | 2010 | 838 | 0.180 |
Why?
|
| Forced Expiratory Volume | 7 | 2015 | 1814 | 0.170 |
Why?
|
| Treatment Refusal | 2 | 2000 | 429 | 0.170 |
Why?
|
| Alzheimer Disease | 8 | 2008 | 8601 | 0.170 |
Why?
|
| Child | 47 | 2021 | 80079 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 7 | 2008 | 3708 | 0.170 |
Why?
|
| Enzymes | 2 | 2013 | 257 | 0.170 |
Why?
|
| Depressive Disorder | 9 | 2012 | 3735 | 0.160 |
Why?
|
| Female | 100 | 2023 | 392148 | 0.160 |
Why?
|
| Parents | 5 | 2019 | 3563 | 0.160 |
Why?
|
| Patient Dropouts | 7 | 2001 | 410 | 0.160 |
Why?
|
| Analysis of Variance | 8 | 2006 | 6224 | 0.150 |
Why?
|
| Malpractice | 8 | 2004 | 556 | 0.150 |
Why?
|
| Male | 90 | 2023 | 360358 | 0.150 |
Why?
|
| Social Isolation | 1 | 2021 | 364 | 0.150 |
Why?
|
| Mathematical Computing | 2 | 2001 | 142 | 0.140 |
Why?
|
| Bulimia Nervosa | 3 | 2012 | 206 | 0.140 |
Why?
|
| Zidovudine | 4 | 2002 | 624 | 0.140 |
Why?
|
| Polymorphism, Genetic | 8 | 2013 | 4242 | 0.140 |
Why?
|
| Exercise | 6 | 2011 | 5886 | 0.140 |
Why?
|
| Family Health | 6 | 2010 | 1253 | 0.140 |
Why?
|
| Siblings | 4 | 2009 | 824 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2015 | 375 | 0.130 |
Why?
|
| Models, Biological | 5 | 2003 | 9461 | 0.130 |
Why?
|
| Therapeutics | 1 | 1996 | 113 | 0.130 |
Why?
|
| Feeding Behavior | 3 | 2008 | 3182 | 0.130 |
Why?
|
| School Health Services | 1 | 1999 | 384 | 0.130 |
Why?
|
| Databases, Genetic | 4 | 2017 | 1742 | 0.130 |
Why?
|
| Predictive Value of Tests | 4 | 2011 | 15251 | 0.130 |
Why?
|
| PUVA Therapy | 2 | 1994 | 101 | 0.130 |
Why?
|
| Gene Dosage | 3 | 2009 | 1217 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 2015 | 3688 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2011 | 10199 | 0.120 |
Why?
|
| Bayes Theorem | 4 | 2012 | 2326 | 0.120 |
Why?
|
| Vital Capacity | 2 | 2013 | 971 | 0.120 |
Why?
|
| Child Health Services | 2 | 1999 | 644 | 0.120 |
Why?
|
| Models, Theoretical | 7 | 2012 | 3567 | 0.120 |
Why?
|
| Monte Carlo Method | 6 | 2008 | 1257 | 0.120 |
Why?
|
| Patient Compliance | 2 | 2002 | 2688 | 0.120 |
Why?
|
| Environmental Exposure | 2 | 2013 | 4483 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2000 | 1034 | 0.110 |
Why?
|
| Cadherins | 2 | 2017 | 901 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 3 | 2015 | 4408 | 0.110 |
Why?
|
| New England | 1 | 2017 | 1051 | 0.110 |
Why?
|
| Receptors, Dopamine D4 | 2 | 2008 | 170 | 0.110 |
Why?
|
| Austria | 3 | 2010 | 206 | 0.110 |
Why?
|
| Interleukin-10 | 3 | 2009 | 1172 | 0.110 |
Why?
|
| Canada | 8 | 2008 | 2118 | 0.110 |
Why?
|
| Health Behavior | 2 | 2008 | 2643 | 0.110 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2005 | 361 | 0.100 |
Why?
|
| Iatrogenic Disease | 7 | 1995 | 538 | 0.100 |
Why?
|
| Renal Dialysis | 9 | 1983 | 1799 | 0.100 |
Why?
|
| Mexico | 4 | 2013 | 756 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2004 | 12447 | 0.100 |
Why?
|
| Age of Onset | 6 | 2017 | 3302 | 0.100 |
Why?
|
| alpha-Macroglobulins | 2 | 2003 | 60 | 0.090 |
Why?
|
| Mood Disorders | 3 | 2003 | 1127 | 0.090 |
Why?
|
| Probability | 8 | 2012 | 2475 | 0.090 |
Why?
|
| Risk | 9 | 2012 | 9604 | 0.090 |
Why?
|
| Nasal Decongestants | 1 | 2010 | 29 | 0.090 |
Why?
|
| Schools | 1 | 1999 | 1483 | 0.090 |
Why?
|
| Risk Factors | 30 | 2017 | 74115 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2002 | 2197 | 0.090 |
Why?
|
| Molecular Epidemiology | 1 | 2012 | 469 | 0.090 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2009 | 29 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2011 | 386 | 0.080 |
Why?
|
| Poverty | 2 | 2021 | 2692 | 0.080 |
Why?
|
| Middle Aged | 52 | 2017 | 220584 | 0.080 |
Why?
|
| Depressive Disorder, Major | 5 | 2009 | 4764 | 0.080 |
Why?
|
| Phenylephrine | 1 | 2010 | 293 | 0.080 |
Why?
|
| Tobacco Use Disorder | 2 | 2006 | 703 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2009 | 2872 | 0.080 |
Why?
|
| Apolipoproteins E | 3 | 2017 | 1443 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 655 | 0.080 |
Why?
|
| Ozone | 1 | 2013 | 483 | 0.080 |
Why?
|
| Least-Squares Analysis | 3 | 2001 | 368 | 0.080 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2009 | 94 | 0.080 |
Why?
|
| HLA-DR Antigens | 1 | 2010 | 602 | 0.080 |
Why?
|
| Pharmacokinetics | 1 | 2008 | 86 | 0.080 |
Why?
|
| Sex Factors | 9 | 2008 | 10548 | 0.080 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2009 | 208 | 0.080 |
Why?
|
| Principal Component Analysis | 2 | 2008 | 943 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2003 | 819 | 0.080 |
Why?
|
| Odds Ratio | 9 | 2008 | 9643 | 0.080 |
Why?
|
| Adolescent Behavior | 2 | 2008 | 1187 | 0.080 |
Why?
|
| Self Disclosure | 2 | 2007 | 249 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 4739 | 0.070 |
Why?
|
| X Chromosome | 2 | 2023 | 816 | 0.070 |
Why?
|
| Plasmodium vivax | 1 | 2009 | 202 | 0.070 |
Why?
|
| Prevalence | 11 | 2010 | 15689 | 0.070 |
Why?
|
| Patient Care Team | 1 | 1999 | 2515 | 0.070 |
Why?
|
| Malaria, Vivax | 1 | 2009 | 166 | 0.070 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2007 | 32 | 0.070 |
Why?
|
| Confidence Intervals | 3 | 2008 | 2925 | 0.070 |
Why?
|
| Health Promotion | 1 | 1999 | 2206 | 0.070 |
Why?
|
| Metagenomics | 1 | 2011 | 463 | 0.070 |
Why?
|
| Life Style | 1 | 1999 | 3904 | 0.070 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1990 | 306 | 0.070 |
Why?
|
| Random Allocation | 13 | 1998 | 2392 | 0.070 |
Why?
|
| Receptors, Nicotinic | 2 | 2015 | 495 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3777 | 0.070 |
Why?
|
| Lung | 6 | 2017 | 9998 | 0.070 |
Why?
|
| Alcoholism | 3 | 2008 | 1972 | 0.070 |
Why?
|
| Adult | 50 | 2016 | 220969 | 0.070 |
Why?
|
| Television | 2 | 1999 | 407 | 0.070 |
Why?
|
| Psoriasis | 2 | 1994 | 944 | 0.070 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2008 | 215 | 0.070 |
Why?
|
| Weight Gain | 3 | 2009 | 2350 | 0.070 |
Why?
|
| Medication Errors | 3 | 1998 | 783 | 0.070 |
Why?
|
| Cluster Analysis | 4 | 2017 | 2700 | 0.070 |
Why?
|
| Receptors, Lipoprotein | 1 | 2006 | 88 | 0.060 |
Why?
|
| Body Composition | 3 | 2006 | 2426 | 0.060 |
Why?
|
| Age Factors | 12 | 2013 | 18381 | 0.060 |
Why?
|
| Sampling Studies | 5 | 2002 | 615 | 0.060 |
Why?
|
| Adolescent | 28 | 2012 | 88234 | 0.060 |
Why?
|
| Fibromyalgia | 2 | 2008 | 405 | 0.060 |
Why?
|
| Mental Disorders | 5 | 2008 | 6826 | 0.060 |
Why?
|
| Cohort Studies | 11 | 2017 | 41457 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2003 | 430 | 0.060 |
Why?
|
| Dysthymic Disorder | 2 | 2002 | 75 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2009 | 868 | 0.060 |
Why?
|
| Antioxidants | 1 | 2013 | 1668 | 0.060 |
Why?
|
| Risk-Taking | 2 | 2008 | 1037 | 0.060 |
Why?
|
| Medication Systems, Hospital | 2 | 1995 | 154 | 0.060 |
Why?
|
| Alcoholic Intoxication | 1 | 1985 | 174 | 0.060 |
Why?
|
| Genetics, Medical | 1 | 2006 | 334 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2011 | 247 | 0.060 |
Why?
|
| Indinavir | 1 | 2003 | 73 | 0.050 |
Why?
|
| Adipose Tissue | 3 | 2006 | 3309 | 0.050 |
Why?
|
| Carrier Proteins | 3 | 2015 | 4935 | 0.050 |
Why?
|
| Prisoners | 1 | 2007 | 314 | 0.050 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1987 | 549 | 0.050 |
Why?
|
| Uremia | 9 | 1983 | 202 | 0.050 |
Why?
|
| Comorbidity | 7 | 2008 | 10505 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 581 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2004 | 242 | 0.050 |
Why?
|
| Reproducibility of Results | 7 | 2010 | 20074 | 0.050 |
Why?
|
| Hematopoietic System | 1 | 1983 | 110 | 0.050 |
Why?
|
| Anxiety Disorders | 3 | 2003 | 2723 | 0.050 |
Why?
|
| Membrane Proteins | 3 | 2009 | 7847 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 602 | 0.050 |
Why?
|
| Anorexia Nervosa | 3 | 2012 | 1361 | 0.050 |
Why?
|
| Estrogens | 1 | 2009 | 1521 | 0.050 |
Why?
|
| Bone Density | 2 | 2006 | 3548 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2003 | 217 | 0.050 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2008 | 452 | 0.050 |
Why?
|
| Computational Biology | 1 | 2014 | 3509 | 0.050 |
Why?
|
| Fetal Growth Retardation | 1 | 2006 | 580 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2005 | 581 | 0.050 |
Why?
|
| Panic Disorder | 1 | 2005 | 613 | 0.050 |
Why?
|
| Blood Urea Nitrogen | 6 | 1983 | 185 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2005 | 733 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 1409 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2014 | 286 | 0.050 |
Why?
|
| Erythrocyte Indices | 1 | 2002 | 144 | 0.050 |
Why?
|
| Respiratory Sounds | 2 | 1997 | 702 | 0.050 |
Why?
|
| Boston | 8 | 2017 | 9313 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 858 | 0.050 |
Why?
|
| HIV Protease Inhibitors | 1 | 2003 | 432 | 0.050 |
Why?
|
| New York | 8 | 2004 | 874 | 0.050 |
Why?
|
| Fetal Development | 1 | 2006 | 769 | 0.040 |
Why?
|
| Aged | 28 | 2017 | 169042 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2002 | 392 | 0.040 |
Why?
|
| Health Surveys | 5 | 2004 | 4037 | 0.040 |
Why?
|
| Ohio | 1 | 2021 | 322 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1994 | 4020 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2014 | 4391 | 0.040 |
Why?
|
| Glutamate Decarboxylase | 1 | 2001 | 239 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2013 | 3411 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2009 | 6016 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2000 | 210 | 0.040 |
Why?
|
| United States | 8 | 2012 | 72272 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2002 | 398 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2002 | 3410 | 0.040 |
Why?
|
| Exons | 2 | 2007 | 2381 | 0.040 |
Why?
|
| Baltimore | 1 | 1999 | 231 | 0.040 |
Why?
|
| Thailand | 2 | 2009 | 287 | 0.040 |
Why?
|
| Menarche | 1 | 2001 | 532 | 0.040 |
Why?
|
| Mutation | 7 | 2021 | 30016 | 0.040 |
Why?
|
| Body Height | 4 | 1995 | 1565 | 0.040 |
Why?
|
| Inpatients | 3 | 1999 | 2544 | 0.040 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 1998 | 102 | 0.040 |
Why?
|
| Cross-Sectional Studies | 10 | 2012 | 26049 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 1504 | 0.040 |
Why?
|
| Angiotensinogen | 1 | 1999 | 161 | 0.040 |
Why?
|
| Hospital Records | 4 | 1991 | 93 | 0.040 |
Why?
|
| Schizophrenia | 3 | 2011 | 6929 | 0.040 |
Why?
|
| Mental Health Services | 2 | 2001 | 1717 | 0.040 |
Why?
|
| Epidemiologic Research Design | 1 | 2001 | 368 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2005 | 2200 | 0.040 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2000 | 415 | 0.040 |
Why?
|
| Spirometry | 2 | 2015 | 928 | 0.040 |
Why?
|
| Migraine Disorders | 2 | 2008 | 1701 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2000 | 484 | 0.040 |
Why?
|
| Bronchodilator Agents | 2 | 2015 | 512 | 0.040 |
Why?
|
| Morbidity | 4 | 1991 | 1750 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 3607 | 0.040 |
Why?
|
| Hospitals | 4 | 1991 | 3877 | 0.040 |
Why?
|
| Brazil | 1 | 2021 | 1228 | 0.040 |
Why?
|
| Follow-Up Studies | 11 | 2008 | 39063 | 0.040 |
Why?
|
| Hospitals, Urban | 2 | 1997 | 500 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2005 | 2024 | 0.030 |
Why?
|
| Markov Chains | 1 | 2000 | 965 | 0.030 |
Why?
|
| Homozygote | 3 | 2011 | 1776 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 1963 | 0.030 |
Why?
|
| Skin Neoplasms | 2 | 1994 | 5812 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2000 | 1490 | 0.030 |
Why?
|
| Hypertension | 4 | 2001 | 8529 | 0.030 |
Why?
|
| Risk Management | 4 | 1995 | 557 | 0.030 |
Why?
|
| Osteoporosis | 1 | 2006 | 1604 | 0.030 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 1999 | 494 | 0.030 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2001 | 574 | 0.030 |
Why?
|
| Medical Audit | 2 | 2004 | 453 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 1998 | 2849 | 0.030 |
Why?
|
| Iron Regulatory Protein 2 | 1 | 2015 | 42 | 0.030 |
Why?
|
| Medical Errors | 1 | 2004 | 1263 | 0.030 |
Why?
|
| Lod Score | 3 | 2004 | 600 | 0.030 |
Why?
|
| Cohort Effect | 1 | 1995 | 39 | 0.030 |
Why?
|
| Penetrance | 1 | 2017 | 382 | 0.030 |
Why?
|
| Air Pollution | 4 | 1997 | 2355 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2012 | 64568 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3752 | 0.030 |
Why?
|
| Drug Therapy | 3 | 2010 | 503 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1997 | 350 | 0.030 |
Why?
|
| Tars | 1 | 1994 | 20 | 0.030 |
Why?
|
| Lipids | 1 | 2006 | 3332 | 0.030 |
Why?
|
| Mothers | 2 | 2021 | 2194 | 0.030 |
Why?
|
| Models, Animal | 1 | 2001 | 2109 | 0.030 |
Why?
|
| Systems Analysis | 1 | 1995 | 169 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2009 | 3220 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 361 | 0.030 |
Why?
|
| Child Development | 1 | 1986 | 2300 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 1779 | 0.030 |
Why?
|
| Thyroid Neoplasms | 1 | 1987 | 2332 | 0.030 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 13382 | 0.030 |
Why?
|
| Serpins | 1 | 2015 | 247 | 0.030 |
Why?
|
| Introns | 2 | 2008 | 968 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2013 | 23972 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2806 | 0.030 |
Why?
|
| Photochemotherapy | 2 | 1994 | 823 | 0.030 |
Why?
|
| Fractures, Bone | 1 | 2006 | 2044 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2002 | 10754 | 0.030 |
Why?
|
| Fruit | 1 | 1999 | 1157 | 0.030 |
Why?
|
| Vegetables | 1 | 1999 | 1191 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2021 | 1438 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1002 | 0.030 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 2013 | 76 | 0.030 |
Why?
|
| Aging | 3 | 2009 | 8699 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 6305 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 56 | 0.030 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2013 | 25 | 0.030 |
Why?
|
| Anti-HIV Agents | 2 | 2000 | 4524 | 0.030 |
Why?
|
| Dietary Fats | 2 | 1999 | 1995 | 0.030 |
Why?
|
| Respiratory Function Tests | 2 | 2002 | 1683 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2007 | 7798 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2013 | 99 | 0.030 |
Why?
|
| Intelligence | 1 | 1998 | 923 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 1985 | 4025 | 0.030 |
Why?
|
| Physicians | 2 | 2006 | 4583 | 0.030 |
Why?
|
| Hospitalization | 6 | 2004 | 10704 | 0.030 |
Why?
|
| Psychopathology | 1 | 1995 | 432 | 0.030 |
Why?
|
| Child, Preschool | 9 | 2008 | 42188 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 471 | 0.030 |
Why?
|
| Prospective Studies | 7 | 2012 | 54360 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5319 | 0.020 |
Why?
|
| Incidence | 5 | 2003 | 21337 | 0.020 |
Why?
|
| Demography | 1 | 2017 | 1643 | 0.020 |
Why?
|
| Depression | 2 | 2002 | 8132 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1998 | 2567 | 0.020 |
Why?
|
| Physician's Role | 1 | 1998 | 917 | 0.020 |
Why?
|
| Premature Birth | 1 | 2004 | 1782 | 0.020 |
Why?
|
| Time Factors | 6 | 2017 | 39913 | 0.020 |
Why?
|
| Perphenazine | 1 | 2011 | 33 | 0.020 |
Why?
|
| Anthropometry | 2 | 2006 | 1338 | 0.020 |
Why?
|
| Dibenzothiazepines | 1 | 2011 | 102 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 1995 | 804 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 565 | 0.020 |
Why?
|
| Hospital Costs | 1 | 1997 | 947 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2003 | 4366 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1996 | 1437 | 0.020 |
Why?
|
| Binge-Eating Disorder | 1 | 2012 | 147 | 0.020 |
Why?
|
| Carcinoma, Basal Cell | 2 | 1994 | 557 | 0.020 |
Why?
|
| Urban Health | 1 | 2013 | 532 | 0.020 |
Why?
|
| Motivation | 1 | 2000 | 2003 | 0.020 |
Why?
|
| Liability, Legal | 1 | 1992 | 210 | 0.020 |
Why?
|
| Pregnancy | 6 | 2021 | 29868 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11736 | 0.020 |
Why?
|
| Alcohol-Related Disorders | 1 | 2012 | 238 | 0.020 |
Why?
|
| Germany | 1 | 2012 | 872 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2009 | 69 | 0.020 |
Why?
|
| Psychometrics | 3 | 2009 | 3060 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2011 | 418 | 0.020 |
Why?
|
| Menopause | 2 | 2009 | 1645 | 0.020 |
Why?
|
| Methods | 1 | 1990 | 1065 | 0.020 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2009 | 99 | 0.020 |
Why?
|
| Health Services Research | 2 | 2004 | 1808 | 0.020 |
Why?
|
| Anxiety | 1 | 2004 | 4570 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2011 | 535 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1994 | 1079 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 1998 | 1669 | 0.020 |
Why?
|
| Aged, 80 and over | 7 | 2011 | 58894 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 244 | 0.020 |
Why?
|
| Auditory Perceptual Disorders | 1 | 2008 | 36 | 0.020 |
Why?
|
| Mutagenicity Tests | 1 | 1987 | 46 | 0.020 |
Why?
|
| Twin Studies as Topic | 1 | 2008 | 103 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 384 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6074 | 0.020 |
Why?
|
| Chlorpheniramine | 1 | 1987 | 13 | 0.020 |
Why?
|
| Carboplatin | 1 | 2011 | 793 | 0.020 |
Why?
|
| Methotrexate | 1 | 1994 | 1716 | 0.020 |
Why?
|
| Education, Continuing | 1 | 2008 | 114 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2009 | 220 | 0.020 |
Why?
|
| Quality of Life | 1 | 2009 | 13347 | 0.020 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 1987 | 59 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1999 | 8516 | 0.020 |
Why?
|
| Histamine H1 Antagonists | 1 | 1987 | 100 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2011 | 2261 | 0.020 |
Why?
|
| Lidocaine | 1 | 1989 | 538 | 0.020 |
Why?
|
| China | 2 | 2006 | 2374 | 0.020 |
Why?
|
| Kartagener Syndrome | 1 | 1986 | 33 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2001 | 9311 | 0.020 |
Why?
|
| Massachusetts | 1 | 1999 | 8833 | 0.020 |
Why?
|
| Mathematics | 3 | 1994 | 707 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 77 | 0.020 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2006 | 118 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1989 | 763 | 0.020 |
Why?
|
| Dietary Proteins | 3 | 1986 | 951 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 1743 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2005 | 43 | 0.020 |
Why?
|
| HIV Infections | 2 | 2003 | 17337 | 0.020 |
Why?
|
| Perception | 1 | 1992 | 1198 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2801 | 0.020 |
Why?
|
| Dietary Services | 1 | 1984 | 17 | 0.020 |
Why?
|
| Data Collection | 4 | 2001 | 3315 | 0.020 |
Why?
|
| Osteoprotegerin | 1 | 2005 | 176 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 1990 | 1155 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2013 | 12334 | 0.020 |
Why?
|
| Epoxy Compounds | 1 | 2005 | 137 | 0.010 |
Why?
|
| Reference Values | 2 | 2003 | 4919 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1999 | 4007 | 0.010 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 167 | 0.010 |
Why?
|
| Epoxide Hydrolases | 1 | 2005 | 122 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1996 | 3039 | 0.010 |
Why?
|
| RANK Ligand | 1 | 2005 | 318 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 2005 | 265 | 0.010 |
Why?
|
| Laboratories | 1 | 1987 | 458 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1987 | 1031 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2006 | 623 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1994 | 4910 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1133 | 0.010 |
Why?
|
| Colonic Diseases, Functional | 1 | 2003 | 39 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2011 | 1730 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2004 | 350 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 2005 | 5780 | 0.010 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1982 | 75 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 783 | 0.010 |
Why?
|
| Length of Stay | 1 | 1997 | 6418 | 0.010 |
Why?
|
| Infant | 6 | 2008 | 36152 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1983 | 157 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20556 | 0.010 |
Why?
|
| Growth | 1 | 1984 | 365 | 0.010 |
Why?
|
| Social Change | 1 | 2003 | 153 | 0.010 |
Why?
|
| Nova Scotia | 1 | 2002 | 34 | 0.010 |
Why?
|
| Cataplexy | 1 | 2003 | 61 | 0.010 |
Why?
|
| Antipsychotic Agents | 2 | 2011 | 3066 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1983 | 181 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 1983 | 204 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 2004 | 272 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2004 | 274 | 0.010 |
Why?
|
| Cilia | 1 | 1986 | 492 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1983 | 325 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 20988 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 1987 | 858 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 2005 | 496 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 516 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2004 | 638 | 0.010 |
Why?
|
| Hematocrit | 1 | 1983 | 623 | 0.010 |
Why?
|
| Minerals | 1 | 1983 | 283 | 0.010 |
Why?
|
| Malaria, Falciparum | 1 | 2009 | 1076 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2009 | 2208 | 0.010 |
Why?
|
| Overweight | 1 | 2012 | 2417 | 0.010 |
Why?
|
| Affect | 1 | 2009 | 1486 | 0.010 |
Why?
|
| Enkephalins | 1 | 2001 | 139 | 0.010 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2001 | 108 | 0.010 |
Why?
|
| Social Environment | 1 | 2006 | 1020 | 0.010 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2001 | 128 | 0.010 |
Why?
|
| Blood Pressure | 3 | 1991 | 8472 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 630 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2009 | 2410 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 2003 | 809 | 0.010 |
Why?
|
| Puberty | 1 | 2003 | 501 | 0.010 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2006 | 517 | 0.010 |
Why?
|
| Infant Behavior | 1 | 2001 | 156 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 2009 | 1740 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1989 | 2234 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 2001 | 407 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 12142 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2006 | 1738 | 0.010 |
Why?
|
| DNA | 2 | 2004 | 7196 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 1990 | 2164 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 1149 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2009 | 1453 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2003 | 829 | 0.010 |
Why?
|
| Nicotine | 1 | 2004 | 679 | 0.010 |
Why?
|
| Europe | 1 | 2006 | 3413 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 11874 | 0.010 |
Why?
|
| Family Practice | 1 | 2001 | 507 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 1989 | 11459 | 0.010 |
Why?
|
| Genomics | 1 | 2014 | 5822 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8998 | 0.010 |
Why?
|
| Finland | 1 | 1999 | 607 | 0.010 |
Why?
|
| beta Carotene | 1 | 1999 | 523 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 2569 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 15828 | 0.010 |
Why?
|
| Eosinophils | 1 | 2002 | 953 | 0.010 |
Why?
|
| Infant, Newborn | 5 | 2006 | 26180 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2009 | 3045 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 1988 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1997 | 114 | 0.010 |
Why?
|
| Causality | 1 | 2003 | 1240 | 0.010 |
Why?
|
| Retrospective Studies | 5 | 2008 | 80566 | 0.010 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 1998 | 197 | 0.010 |
Why?
|
| Platelet Count | 1 | 1999 | 780 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2001 | 1131 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2000 | 673 | 0.010 |
Why?
|
| Pharmacies | 1 | 1998 | 167 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12719 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4570 | 0.010 |
Why?
|
| Pre-Eclampsia | 1 | 2006 | 1230 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2002 | 1502 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 3415 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2006 | 1935 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 1991 | 4321 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 11116 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2012 | 4416 | 0.010 |
Why?
|
| Animals | 3 | 2001 | 168201 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2003 | 1528 | 0.010 |
Why?
|
| Child Behavior | 1 | 2001 | 848 | 0.010 |
Why?
|
| Vitamin E | 1 | 1999 | 872 | 0.010 |
Why?
|
| Heart Diseases | 2 | 2001 | 2778 | 0.010 |
Why?
|
| Gestational Age | 1 | 2004 | 3577 | 0.010 |
Why?
|
| Allergens | 1 | 2002 | 1429 | 0.010 |
Why?
|
| Medical Records | 2 | 1991 | 1407 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6925 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2001 | 2697 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 1998 | 709 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 4341 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1983 | 2049 | 0.010 |
Why?
|
| Anemia | 1 | 1983 | 1504 | 0.010 |
Why?
|
| Prognosis | 2 | 2011 | 29600 | 0.010 |
Why?
|
| Selection Bias | 1 | 1995 | 359 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2003 | 1810 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2001 | 1872 | 0.010 |
Why?
|
| Young Adult | 2 | 2009 | 59179 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1983 | 4160 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1983 | 2565 | 0.010 |
Why?
|
| Weight Loss | 1 | 2004 | 2682 | 0.010 |
Why?
|
| Urban Population | 1 | 2000 | 2033 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1979 | 1474 | 0.010 |
Why?
|
| Heterozygote | 1 | 1999 | 2780 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1997 | 1663 | 0.010 |
Why?
|
| Insurance Claim Reporting | 1 | 1991 | 165 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2003 | 7050 | 0.010 |
Why?
|
| Netherlands | 1 | 1995 | 2221 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1999 | 2016 | 0.010 |
Why?
|
| Hospitals, Rural | 1 | 1991 | 176 | 0.010 |
Why?
|
| Hospitals, University | 1 | 1991 | 564 | 0.010 |
Why?
|
| Decision Support Systems, Clinical | 1 | 1998 | 1167 | 0.010 |
Why?
|
| Systole | 1 | 1991 | 935 | 0.010 |
Why?
|
| Diastole | 1 | 1991 | 781 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2003 | 12758 | 0.000 |
Why?
|
| Wound Infection | 1 | 1991 | 244 | 0.000 |
Why?
|
| Coronary Disease | 2 | 1983 | 5912 | 0.000 |
Why?
|
| Pharmaceutical Preparations | 1 | 1997 | 1086 | 0.000 |
Why?
|
| Astemizole | 1 | 1987 | 2 | 0.000 |
Why?
|
| Antidepressive Agents | 1 | 1999 | 2896 | 0.000 |
Why?
|
| Peer Review | 1 | 1989 | 217 | 0.000 |
Why?
|
| Mutagens | 1 | 1987 | 179 | 0.000 |
Why?
|
| Dextrocardia | 1 | 1986 | 37 | 0.000 |
Why?
|
| Dyneins | 1 | 1986 | 124 | 0.000 |
Why?
|
| Long-Term Care | 1 | 1989 | 631 | 0.000 |
Why?
|
| Insurance Claim Review | 1 | 1990 | 741 | 0.000 |
Why?
|
| California | 1 | 1989 | 1430 | 0.000 |
Why?
|
| Salmonella typhimurium | 1 | 1987 | 347 | 0.000 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2003 | 4575 | 0.000 |
Why?
|
| Quality Control | 1 | 1987 | 831 | 0.000 |
Why?
|
| Minority Groups | 1 | 1991 | 1202 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1991 | 1265 | 0.000 |
Why?
|
| Disability Evaluation | 1 | 1991 | 1835 | 0.000 |
Why?
|
| Skinfold Thickness | 1 | 1983 | 163 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 2001 | 5835 | 0.000 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 1983 | 125 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1995 | 3742 | 0.000 |
Why?
|
| Nutritional Requirements | 1 | 1983 | 274 | 0.000 |
Why?
|
| Mental Health | 1 | 1995 | 3251 | 0.000 |
Why?
|
| Disabled Persons | 1 | 1991 | 1226 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1991 | 2637 | 0.000 |
Why?
|
| Phosphates | 1 | 1983 | 769 | 0.000 |
Why?
|
| Maternal Health Services | 1 | 1984 | 460 | 0.000 |
Why?
|
| Potassium | 1 | 1983 | 1311 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1983 | 2495 | 0.000 |
Why?
|
| Health Status | 1 | 1991 | 4075 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1990 | 2491 | 0.000 |
Why?
|
| Sinusitis | 1 | 1986 | 991 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1983 | 1803 | 0.000 |
Why?
|
| Eating | 1 | 1983 | 1535 | 0.000 |
Why?
|
| Creatinine | 1 | 1981 | 1896 | 0.000 |
Why?
|
| Clinical Competence | 1 | 1991 | 4789 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1998 | 13635 | 0.000 |
Why?
|
| Heart Failure | 1 | 1979 | 11669 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1990 | 14648 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1983 | 1201 | 0.000 |
Why?
|
| Calcinosis | 1 | 1983 | 1469 | 0.000 |
Why?
|
| Mice | 1 | 2001 | 81368 | 0.000 |
Why?
|
| Mortality | 1 | 1981 | 2899 | 0.000 |
Why?
|
| Calcium | 1 | 1983 | 5717 | 0.000 |
Why?
|
| Vitamin D | 1 | 1983 | 3302 | 0.000 |
Why?
|
| Neoplasms | 1 | 1998 | 22131 | 0.000 |
Why?
|
| Diet | 1 | 1983 | 8048 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1983 | 15498 | 0.000 |
Why?
|